From Name:
From Email:
To Name:
To Email:

Optional Message:


NeuroSigma spinout NSVascular looks to commercialize UCLA stent technology

from MassDevice

NeuroSigma Inc. spun out NSVascular Inc. to develop two stent lines using thin-film nitinol technology developed at the University of California -Los Angeles under an exclusive licensing agreement. Los Angeles-based NeuroSigma said its new subsidiary plans to develop one type of stent to treat brain aneurysms and another to treat peripheral artery disease. The UCLA technology uses a "shape-memory" alloy of nickel and titanium called nitinol — widely used to make stents for a variety of indications — in a thin with "super-hydrophylic" properties that reduce the ability of blood platelets to adhere to the stent's surface. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063